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Targeted Identification of Metastasis-
associated Cell-surface Sialoglycoproteins in
Prostate Cancer*□S
Lifang Yang‡, Julius O. Nyalwidhe‡, Siqi Guo§, Richard R. Drake‡,
and O. John Semmes‡¶
Covalent attachment of carbohydrates to proteins is one
of the most common post-translational modifications.
At the cell surface, sugar moieties of glycoproteins con-
tribute to molecular recognition events involved in can-
cer metastasis. We have combined glycan metabolic
labeling with mass spectrometry analysis to identify and
characterize metastasis-associated cell surface sia-
loglycoproteins. Our model system used syngeneic pros-
tate cancer cell lines derived from PC3 (N2, nonmeta-
static, and ML2, highly metastatic). The metabolic
incorporation of AC4ManNAz and subsequent specific la-
beling of cell surface sialylation was confirmed by flow
cytometry and confocal microscopy. Affinity isolation of
the modified sialic-acid containing cell surface proteins
via click chemistry was followed by SDS-PAGE separation
and liquid chromatography-tandem MS analysis. We iden-
tified 324 proteins from N2 and 372 proteins of ML2. Using
conservative annotation, 64 proteins (26%) from N2 and
72 proteins (29%) from ML2 were classified as extracel-
lular or membrane-associated glycoproteins. A selective
enrichment of sialoglycoproteins was confirmed. When
compared with global proteomic analysis of the same
cells, the proportion of identified glycoprotein and cell-
surface proteins were on average threefold higher using
the selective capture approach. Functional clustering of
differentially expressed proteins by Ingenuity Pathway
Analysis revealed that the vast majority of glycoproteins
overexpressed in the metastatic ML2 subline were in-
volved in cell motility, migration, and invasion. Our ap-
proach effectively targeted surface sialoglycoproteins
and efficiently identified proteins that underlie the meta-
static potential of the ML2 cells. Molecular & Cellular
Proteomics 10: 10.1074/mcp.M110.007294, 1–16, 2011.
Covalent attachment of carbohydrates to proteins is one of
the most common post-translational modifications with more
than 50% of eukaryotic proteins thought to be glycosylated
(1). As would be expected, protein glycosylation is prevalent
in membrane and secreted proteins where they play a
decisive role in cellular recognition events involved in cell
adhesion, cell-to-cell communication, and receptor-ligand
interactions (2–4). Glycans also critically influence the physio-
chemical properties of proteins that impact protein folding,
solubility, and turnover (5, 6). As a direct result of its impor-
tance in a variety of biological and pathological processes,
changes in glycosylation of proteins are strongly correlated
with cancer prognosis and the malignant properties of tumor
cells. This includes changes in the levels of sialylation and
fucosylation, polylactosaminylation, higher-ordered N-
linked branching, and truncated O-linked glycans (7–10).
Cell-surface glycoproteins commonly contain sialic acid
(SA)1 as the monosaccharide located on the nonreducing
terminus of glycans. Evidence from both patient histochemi-
cal analysis and experimental tumor models demonstrate that
altered sialylation of tumor cell surfaces is associated with a
metastatic tumor phenotype (11, 12). These surface sialylation
changes have been reported reflecting the amount, type,
distribution, and bonding of sialic acids to adjacent mole-
cules. For instance, a positive correlation can be established
between the levels of cell-surface sialylation and metastatic
ability of various experimental tumors (13, 14). In addition, the
distribution of sialic acid on specific N- or O-linked oligosac-
charides has been demonstrated to alter the metastatic po-
tential of cancer cell lines (15). In some cases tumor develop-
ment has been associated with over expression of 1–6
branching that results in increased number of Gal1–
4GlcNAc structures available for sialylation (16–18). There-
fore, exploring cell-surface sialylation changes during tumor
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opportunities to identify sensitive and specific cancer
biomarkers.
Elucidation of structural details of cell-surface glycosylation
by mass spectrometry is hampered by the limited relative
abundance of surface proteins compared with cytosolic com-
ponents, the complex and microheterogeneous nature of gly-
cans, and the inherent complexities of deciphering low energy
carbohydrate fragmentation ions versus higher energy pep-
tide fragments in complex mixtures (19). The type of mass
spectrometer and ionization energies to be used, and the
complexity of the sample, are critical parameters for success-
ful glycoprotein analysis (19). In recent years, lectin- and
antibody-based affinity selection has been used with some
success to purify glycoproteins and glycopeptides with spe-
cific structures (20–24). Other approaches for glycopeptide
characterization arise from the exploitation of glycan chemical
reactivity. Larsen et al. took advantage of the high affinity of
titanium dioxide microcolumns toward SA residues to isolate
SA-containing peptides from serum under highly acidic con-
ditions (25). Two similar approaches, involving hydrazide and
boronic acid chemistry, capitalize on the cis-diols present in
monosaccharides. Zhang et al. described the use of hydra-
zide chemistry for purification by directly coupling of glyco-
proteins to a solid support (26, 27). Similarly, Sparbier et al.
used boronic acid -functionalized beads to covalently capture
glycoproteins followed by elution with acid (28). Although
these methods are effective at the enrichment and identifica-
tion of broad classes of glycoproteins/glycopeptides, they still
lack the specificity and selectivity required for analysis of
specific cell surface glycoproteins that could serve as poten-
tial cancer biomarkers.
In this study, we describe a glycoproteomic identification
strategy for the selective detection, isolation and identification
of cell-surface sialoglycoproteins from cultured cell lines. The
method utilizes the sialic acid biosynthetic pathway for the
incorporation of monosaccharide bearing bioorthogonal
functional handles (tetraacetylated N-azidoacetyl-D- man-
nosamine) into cellular sialic acid (29–31). These reagents
have previously been used to label and visualize cell surface
expression of glycoproteins via microscopy. To illustrate the
potential of using this cell labeling procedure in biomarker
discovery, we combined it with an MS-based proteomics
approach as applied to a syngeneic metastatic prostate can-
cer cell line model.
EXPERIMENTAL PROCEDURES
Materials—CompleteTM protease inhibitors were purchased from
Roche Applied Sciences (Indianapolis, IN), sequencing grade trypsin
was from Promega (Madison, WI), and Immobilon-FL PDVF mem-
brane was from Millipore (Billerica, MA). Protein-free blocking buffer
and high capacity streptavidin agarose resin was from Thermo Sci-
entific (Rockford, IL). Dulbecco’s modified Eagle media (DMEM) and
fetal bovine serum (FBS) were from Invitrogen (Carlsbad, CA). Antibi-
otics-antimycotic, Click-iTTM ManNAz metabolic glycoprotein rea-
gent, Click-iT Biotin Protein Analysis Detection Kit, propidium iodide,
fluorescein conjugated streptavidin (streptavidin-FITC), 4–12% Nu-
PAGE® Bis-Tris gels, and lithium dodecyl sulfate buffer were from
Invitrogen (Carlsbad, CA). 2 Laemmli buffer, 7.5% Criterion® Tris-
HCl Gel, and Bio-Safe Coomassie blue were from Bio-Rad (Hercules,
CA). The streptavidin-IR 800 and species-specific secondary antibod-
ies conjugated to IR 800 or IR700 were from Li-COR Biosciences
(Lincoln, PA).
Cell Lines—PC3-N2 and PC3-ML2, two sublines of PC3 prostate
cancer cells, were kindly provided by Dr. Mark Stearns (Drexel Uni-
versity). The PC3 cell line was originally derived from a skeletal
metastasis in a patient with primary prostate adenocarcinoma. The
N2 and ML2 cell lines have been developed on the basis of their
invasiveness in vitro and metastatic potential in vivo. Both cells were
tumorigenic when injected subcutaneously in Severe combined im-
munodeficiency mice. However, N2 cells were unable to migrate
through a Matrigel-coated membrane in vitro as well as induce me-
tastases in severe combined immunodeficiency mice, whereas ML2
cells were highly invasive in vitro and induced skeletal metastases in
more than 80% of mice (32).
Cell Culture and Metabolic Labeling—N2 and ML2 cells were cul-
tured in DMEM medium supplemented with 10% FBS and 1% anti-
biotics at 37 °C with 5% CO2. For metabolic labeling, growth medium
was replaced at 70% cell confluence with complete DMEM medium
containing the indicated concentration of an azido-modified sugar,
tetraacetylated N-azidoacetyl-D- mannosamine (AC4ManNAz), or a
control sugar, N-acetyl-D-mannosamine (ManNAc), and cells were
incubated for 1–3 days. Cells then were dissociated from the plastic
surface by nonenzyme dissociation buffer.
Flow Cytometric Analysis of Cell-surface Sialic Acid Labeling—
After metabolic labeling, N2 and ML2 cells were harvested, washed
with 0.1% FBS/phosphate-buffered saline (PBS), and resuspended
(106 cells) in 100 l click reaction solution with the indicated amount
of each component. The reaction was incubated at room temperature
for 30 min, and then cells were washed three times with 0.1% FBS/
PBS. Cells were subsequently stained with streptavidin-FITC (1 g/
sample in 100 l 2% FBS/PBS) for 30 min at 4 °C, and washed with
2% FBS/PBS three times. Prior to flow cytometric analysis, cells were
incubated with 1 g/ml propidium iodide in 500 l 2% FBS/PBS at
4 °C for 20 min. Data was acquired by FACScalibur (BD Biosciences,
San Jose, CA) and analyzed by Flowjo software (Tree Star Inc.,
Ashland, OR).
Confocal Microscopy Analysis of Cell-surface Sialic Acid Label-
ing—N2 and ML2 cells were seeded onto glass coverslips in 6-well
plates containing 10% FBS/DMEM. Growth medium was supple-
mented with 40 M AC4ManNAz or ManNAc for 3 days. Cells were
washed with ice-cold PBS, fixed with 2% paraformaldehyde, and
then subjected to click reaction solution (25 l biotin-alkyne, 2.5 l
CuSO4, 2.5 l and 5 l for component D and E, 65 l PBS). Subse-
quently, the fixed and labeled cells were washed with PBS and
stained with streptavidin-FITC and the nuclei were counterstained
with propidium iodide. The coverslips were inverted onto glass slides
and mounted with VectorShield medium (Vector Labs, Burlingame,
CA), and sealed with nail polish. Fluorescent images were examined
and captured with a Zeiss confocal microscope.
Cell-surface Sialoglycoprotein Labeling and Detection in Cell Ex-
tracts—N2 and ML2 cells were seeded in 15-cm dishes and treated
with the optimized labeling conditions for AC4ManNAz and ManNAc
(20 M for 1 day) in growth medium. The cells were then harvested
with nonenzymatic dissociation buffer, 5  107 cells were collected
and washed with 0.1% FBS/PBS. Harvested cells were subjected to
click reaction solution as described above. After chemical conjuga-
tion, cell pellets were washed with ice-cold PBS twice to remove
unreacted reagents and then lysed in lysis buffer I (1% Nonidet P-40,
150 mM NaCl, protease inhibitor, 100 mM sodium phosphate, pH7.5)
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using a Dounce homogenizer. The total cell lysate was further cleared
by methanol-chloroform precipitation and resolved in lysis buffer II
(1% SDS, protease inhibitor, 50 mM Tris-HCl, pH 8.0). Protein con-
centrations were measured using the BCA protein assay (Pierce). To
detect biotin-labeled sialoglycoproteins in cell extracts, 20 g of
labeled protein lysate was resolved by SDS-PAGE. Electrophoresed
proteins were transferred onto PVDF membrane, blocked with Odys-
sey Blocking Buffer (Rockland Immunochemicals, Gilbertsville, PA),
probed with streptavidin-IR 800, and visualized and quantified using
an Odyssey infrared imaging system.
Sialoglycoprotein Capture—Streptavidin beads were pretreated
with protein-free blocking buffer overnight at 4 °C and washed five
times with PBS. Cell lysate (2 mg) was incubated with 100 l beads in
0.3% Nonidet P-40/PBS overnight at 4 °C with a rotating shaker. The
captured glycoproteins were washed intensively with modified RIPA
buffer (150 mM NaCl, 2% SDS, 1% Nonidet P-40, 1% Na Deoxy-
cholate, 50 mM Tris-HCl, pH 7.5). Bound material was eluted by
boiling for 10 min in 100 l 2 Laemmli sample buffer. For assess-
ment of capture efficiency, 10 l of the eluent, along with the input
and flow-through fractions were separated by SDS-PAGE and probed
with streptavidin-IR 800 by Western blot.
One-dimensional Gel Electrophoresis and In-gel Digestion—Cap-
tured glycoproteins (45 l) were separated on a 1.0 mm 7.5% Tris-
HCl polyacrylamide gels. Gels were stained with Coomassie blue and
imaged on a Typhoon 9410 (GE Healthcare, Piscataway, NJ). Twenty-
seven equally spaced gel pieces were excised from each lane, span-
ning the full height of the gel (30–300 kDa). Individual gel pieces were
destained with 25 mM NH4HCO3 in 50% acetonitrile (ACN), reduced
with 20 mM dithiothreitol in 25 mM NH4HCO3 for 45 min at 56 °C, and
alkylated with 55 mM iodoacetamide in 25 mM NH4HCO3 in the dark
for 1 h at room temperature. After washing, the gel pieces were
dehydrated with ACN and dried using a speed vac. Trypsin (12.5
ng/l in 25 mM NH4HCO3, pH 8.0) was added to each gel piece, and
the gel pieces were allowed to swell on ice for 1 h. Excess trypsin was
removed, replaced with 25 mM NH4HCO3, 10% ACN, pH 8.0, and the
mixture was incubated overnight at 37 °C. The digest was collected
and peptides were extracted 2X with 50% ACN/0.5% formic acid. The
combined extracts were then dried using a SpeedVac for subsequent
LC-MS/MS analysis.
Whole-cell Extract and In-solution Digestion—For N2 and ML2 cell
lysate experiments; both cell lines were cultured in complete growth
medium to 80% confluence. Cells were then washed with PBS and
the pellet resuspended in 160 l dissolution buffer containing 100 mM
NH4HCO3 and TFE (1:1 v/v). The samples were sonicated 3 for 20 s
and incubated at 60 °C for 1 h. The lysates were centrifuged to
remove cell debris and unbroken cells and the supernatant was
collected. The protein concentration of the samples was determined
by BCA assay and normalized for each sample and before reduction
and alkylation with TCEP and iodoacetamide respectively. The con-
centration of TFE was reduced to 5% by the addition of 1.4 ml 100 mM
NH4HCO3. Trypsin was added at a ratio of 1:50 protease to protein
and the digestion proceeded at 37 °C for 18 h with constant mixing.
After digestion the sample was dried down in a SpeedVac, desalted
and lyophilized before liquid chromatography-tandem MS (LC-MS/
MS) analysis.
LC-MS/MS Analysis—Digests were resuspended in 20 l Buffer A
(5% ACN, 0.1% formic acid, 0.005% heptafluorobutyric acid) and 15
l loaded onto a 12-cm  0.075 mm fused silica capillary column
packed with 5 M diameter C-18 beads (The Nest Group, Southbor-
ough, MA) using a programmed automatic injection. Peptides were
eluted over 80 min, by applying a 0–80% linear gradient of Buffer B
(95% acetonitrile, 0.1% formic acid, 0.005% HFBA) at a flow rate of
200 l/min with a precolumn flow splitter resulting in a final flow rate
of 300 nl/min directly into the source. In some cases, the gradient
was extended to 150 min to acquire more MS/MS spectra. An LTQ™
Linear Ion Trap (ThermoFinnigan, San Jose, CA) was run in an auto-
mated collection mode with an instrument method composed of a
single segment and five data-dependent scan events with a full MS
scan followed by four MS/MS scans of the highest intensity ions.
Normalized collision energy was set at 35, activation Q was 0.250
with minimum full scan signal intensity at 1  105 with no minimum
MS2 intensity specified. Dynamic exclusion was turned on utilizing a
three-minute repeat count of 2 with the mass width set at 1.0 m/z.
Peak lists were generated using Xcaliber (version 2.1). Sequence
analysis was performed with MASCOT (version 2.2.03) using the
SwissProt 57.1 database with a human taxonomy filter enabled that
contained 20,405 entires. The database searches were performed
with fixed modification as carbamidomethyl (Cys) and variable mod-
ifications as oxidation (Met) and deamidation (Asn, Gln). Enzyme
specificity was selected to trypsin with 1 missed cleavage. The mass
tolerance was set at 1 for precursor ions and 0.8 for fragment ions.
Threshold score for acceptance of individual spectra was set at 0.05.
All the MS/MS spectra were manually inspected to verify the validity
of the database search results. False discovery rates were estimated
to be 0.25% on the protein level by searching a decoy version of the
SwissProt protein database. The relative abundance of peptides was
estimated by spectral counting.
Deglycosylation Assays—Enymatic deglycosylation of samples
was performed prior to analysis by western. For PNGase F digestions,
cell lysates (20 g) were denatured and reduced for 10 min at 100 °C
in 0.5% SDS and 1% 2-mercaptoethanol. The samples were then
adjusted to 1% Nonidet P 40 and 50 mM sodium phosphate, pH 7.5,
and incubated with PNGase F (1,000 NEB units) overnight at 37 °C.
The experiments using neuraminidase reactions were adjusted to 50
mM sodium acetate, pH 6.0 prior to incubation overnight at 37 °C with
50 NEB units neuraminidase per 20 g of protein. Deglycosylation
digestion of Fetuin was used to optimize conditions (data not shown).
Western Blot Analysis—Whole-cell lysates were collected in M-
PER lysis buffer containing 1x protease inhibitor mixture. The protein
concentration was determined by the BCA protein assay. Cell lysates,
streptavidin pull-down fractions and deglycosylated protein samples
were separated by electrophoresis through 4–12% or 7.5% SDS-
PAGE and then transferred to Immobilon-FL PDVF membranes.
Membranes were blocked in LiCor blocking buffer (Rockland Immu-
nochemicals, Gilbertsville, PA) diluted with PBS (1:1), then incubated
with anti-CDCP1 polyclonal (#4115, 1:1000, Cell Signaling Technol-
ogy, Danvers, MA), or anti-integrin 1 mouse monoclonal (#610467,
0.1 g/ml, BD PharMingen, San Diego, CA) primary antibodies over-
night at 4 °C. After 5 washes in PBS, membranes were incubated
with species-specific (goat anti-rabbit, 1:15,000; goat anti-mouse,
1:15,000) IRDye700- or IRDye800-conjugated secondary antibodies
for 1 h at room temperature, and visualized with a LiCor Odyssey
infrared imager (LiCor, Lincoln, NE). Consistent protein loading was
determined by reprobing membranes stripped in Restore Western
blot stripping buffer with anti-actin antibody (#612656, 0.1 g/ml, BD
PharMingen, San Diego, CA) or anti-GAPDH antibody (#25778,
1:2000, Santa Cruz Biotechnology, Santa Cruz, CA).
Bioinformatic Analysis—Initial basic information on the structure of
the identified proteins was obtained through literature reports. The
ProteinID Finder (Proteome Solutions) program was employed to
extract such available information from the UniProt database. Be-
cause of the limited annotation of protein glycosylation for most
human proteins and the shortage of subcellular location information
for hypothetical proteins and functionally uncharacterized proteins,
we also subjected each identified protein to prediction algorithms
based on protein sequence analysis. For protein glycosylation we
used NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/) to pre-
dict the possible presence of the consensus NXS/T glycosylation
Analysis of Cell-surface Sialoglycoproteins
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motif. For subcellular location, all identified proteins were analyzed
with two transmembrane prediction algorithms SOSUI (http://bp.nuap.
nagoya-u.ac.jp/sosui/sosui) and TMHMM (http://www.cbs.dtu.dk/
services/TMHMM-2.0/) indicating hydrophobic protein sequence
regions.
To generate the lists of cell-surface glycoproteins uniquely ex-
pressed in N2 or ML2 cells, identified proteins were required to meet
the following 3 criteria: (a) identified from one cell line; (b) unique
peptide  1, and NXS/T motif  1 or UniProt indicated N-linked or
O-linked glycosylation; and (c) transmembrane region  1, or UniProt
membrane subcellular location.
The list of identified proteins that were unique to each experimental
group was subjected to the commercially available curator database
software Ingenuity Pathways Analysis (IPA) to determine their molec-
ular function and interacting networks.
RESULTS
Methodology Overview—Our strategy for interrogation of
cell surface sialoglycoproteins using selective chemical tag-
ging followed by high-affinity enrichment and GeLC-MS/MS
analysis is summarized in Fig. 1. The method consists of
several steps: (1) metabolic labeling of N2 and ML2 cells with
the azide-containing mannose analog, peracetylated azido-
mannose (AC4ManNAz); (2) chemoselective conjugation of
azide sugars with a biotinylated alkyne capture reagent via Cu
(I) catalyzed click chemistry in live cells; (3) affinity enrichment
of the labeled cell-surface sialylated proteins by streptavidin
capture; and (4) separation by one-dimensional gel electro-
phoresis and identification by LC-MS/MS. When compared
with other published approaches, the theoretical advantage of
our approach is the targeted selectivity for sialyl glycosylated
proteins on the cell surface.
Efficient Cell Surface Expression of AC4ManAz-Sialoglyco-
proteins—A critical parameter in the proposed strategy is the
efficient labeling and surface expression of the azide-contain-
ing sialoglycoproteins. N2 and ML2 cells were subjected to
metabolic incorporation of AC4ManNAz, conjugated with
biotin with the click reaction, and subsequently stained with
streptavidin-FITC to visualize the glycans harboring the azide
group. We conducted fluorescence-assisted flow cytometric
analysis of nonpermeabilized cells for determining the effi-
ciency of streptavidin-FITC labeling. As quantified by flow
cytometry (Fig. 2A), the AC4ManNAz-treated N2 and ML2
cells displayed 80–100 fold greater FITC-specific fluo-
rescence intensity than the control ManNAc-treated and un-
treated cells. This result demonstrates that the azide moieties
were efficiently incorporated into cellular glycans. We next
conducted confocal microscopy analysis of streptavidin la-
beled cells to specifically assess the cellular location of the
azide-modified glycans. As seen in Fig. 2B, prominent FITC
staining primarily at the cell membrane was observed when
the cells were subjected to metabolic incorporation of
ManNAz. Consistent with flow cytometric data, confocal mi-
croscopic analysis of cells treated with control ManNAc dis-
played much reduced staining, confirming the labeling via
azide-containing glycans is specific. Furthermore, there was
no evidence of cell surface labeling for the control groups. We
further optimized the azide labeling and click reaction to max-
imize cell viability/vigor (see supplemental Fig. S1), and de-
termined that 24 h incubation of 20 M AC4ManNAz and 25%
(v/v) biotin-alkyne was optimal.
Targeted Isolation of Cell-surface Sialoglycoproteins—Hav-
ing demonstrated efficient labeling of cell surface glycocon-
jugates, we continued with a general characterization of
whole-cell lysates of Biotin-labeled glycoconjugates via SDS-
PAGE separation and visualization by reaction with streptavi-
din-IR800. Expression of -actin was used for normalization.
Overall sialylation, as judged by streptavidin staining, was
restricted to extracts from the ManNAz labeled cells (Fig. 3A).
In addition, there appeared to be greater sialylated glycopro-
teins in the ML2 cell line when compared with the N2 cell line.
FIG. 1. Experimental workflow. (1) Metabolic labeling of cells with the mannose analog, peracetylated azido-mannose (AC4ManNAz). (2)
Chemoselective conjugation of azido sugars with a biotinylated alkyne capture reagent via Cu (I) catalyzed click chemistry. (3) Lysis of labeled
cells. (4) Affinity purification using streptavidin (SAv) resins. (5) Elution of captured sialoglycoproteins. (6) SDS-PAGE separation of sialogly-
coproteins. (7) Isolation of gel slice and subsequent digestion and release of peptides. (8) Analysis of peptides by LC-MS/MS. (9) Bioinformatic
analysis.
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We also observed a major protein band that migrated just
under 150 kDa and reacted with streptavidin. These observa-
tions were consistent with the prior immunofluorescence
analyses in demonstrating a specific uptake and labeling of
the ManNAz treated cells.
We next examined the efficiency of our system for the
enrichment of biotin-labeled sialoglycoproteins. The above
whole-cell lysates were incubated with streptavidin-deriva-
tized beads as described. The bound sialoglycoproteins were
eluted by boiling and subjected to SDS-PAGE analysis. In
FIG. 2. Labeling of cell surface sialoglycoproteins. A, Flow cytometry analysis of N2 and ML2 cells treated with AC4ManNAz or ManNAc.
Intact cells were biotin-tagged through click reaction, and visualized with streptavidin-FITC. PI negative gated FACS histogram showing three
populations of cells: control cells (red), cells treated with ManNAc (gray filled), and cells treated with 40 M AC4ManNAz (green) for 3 days.
B, Confocal microscopy of N2 and ML2 cells for visualization of the fluorescently labeled cell-surface sialoglycoproteins. Cells were treated with
40 M AC4ManNAz or ManNAc for 3 days and then fixed, conjugated with biotin-alkyne via click reaction and “stained” with streptavidin-FITC
(green) and PI (red).
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both cell types we observed a dramatic enrichment for biotin-
conjugated proteins in the bound and eluted fractions from
the ManNAz-treated cells (Fig. 3B). In contrast there was
dramatically reduced overall staining of biotin-labeled protein
in the ManNAc-labeled control cells. We again observed an
intense signal at sub-150 Kda in eluted fractions from cells
treated with ManNAz, and absent or minimal signal in flow-
through fractions and eluent from the control group. These
results demonstrate efficient capture and enrichment of the
azide-labeled proteins.
Identification of Surface Glycoproteins by Mass Spectrom-
etry—Because we were able to establish both efficient cell
surface labeling and effective isolation of sialoglycoproteins,
we next performed a proof-of-principle experiment for the
application of this approach to the identification of sialogly-
coproteins differentially expressed between ML2 and N2 cell
lines. The cells were processed for metabolic labeling as
described above, the tagged proteins were enriched with
streptavidin (SAv) resins, the eluted proteins separated by
SDS-PAGE, and analyzed by LC-MS/MS. In total, 538 nonre-
dundant proteins were identified. This total derived from 324
proteins from the N2 line and 372 proteins from the ML2 line
when metabolically labeled with ManNAz. In contrast the con-
trol cells lacking ManNaz yielded 132 proteins from the N2 line
and 75 proteins from the ML2 line. The total number of pro-
teins identified using a sliding scale for unique peptides is
shown in Table I. Approximately 60% of proteins identified
contained two or more unique peptide hits. Supple-
mental Table 1, A–D contains detailed information on all of the
proteins identified for N2, ML2, and their controls. Another
purpose of setting up control groups was to evaluate the
extent of nonspecific interaction between the SAv resin and
proteins in the N2 and ML2 cell lysates. Although a preblock-
ing step and high detergent resin wash was carried out,
several proteins were still identified in the control groups.
Most of these proteins were high abundant housekeeping
proteins, such as actin, tubulin, plectin-1, pyruvate carboxy-
lase, pyruvate kinase, and heat shock proteins. These pro-
teins were subtracted from the list of total proteins identified
in the treated groups, further narrowing the pool of proteins
identified as cell surface molecules (216 proteins for N2 and
245 for ML2 group).
The enrichment efficiency for sialoglycoproteins is a key
factor in characterization of the utility of this methodology. As
was shown in Fig. 3, the presence of sialoglycoproteins was
significantly enhanced after affinity chromatography by SAv
beads when compared with raw cell lysate or processed
control extracts (ManNAc). The specific enrichment of glyco-
FIG. 3. Capture and enrichment of azide-tagged sialoglycoproteins. A, Detection of sialylated glycoprotein in cell lysates. N2 and ML2
cells were metabolically labeled with 20 M ManNAz for 24 h and conjugated with 25% (v/v) biotin-alkyne. Cells were lysed and total protein
was extracted as described under “Experimental Procedures.” Top panel: Protein was resolved by SDS-PAGE and visualized by incubation
with streptavidin-IR 800. Reactive bands indicate sialylated glycoproteins. The same blot was probed with anti--actin to verify equal protein
loading. The relative expression of sialylated glycoproteins after normalization with the -actin is shown at the bottom of each lane.
B, Enrichment of azide-tagged sialoglycoproteins by affinity chromatography. Azide-tagged and biotin-conjugated sialoglycoproteins from the
total lysate of N2 and ML2 cells were captured by streptavidin beads, separated by SDS-PAGE and visualized by reaction with streptavidin-IR
800. Shown are the results from 20 g of postclick cell lysate (Input), 5% of the flow through material that did not bind to the beads
(Flow-Through), 5% of the eluted material from 2 mg of protein that bound to the beads (Eluent). In, input; FT, flow through; E, eluent. Shown
is a representative of four experimental replicates.
TABLE I




N2-ManNAz N2-ManNAc ML2-ManNAz ML2-ManNAc
1 128 64 153 44
2 62 24 72 10
3 29 13 47 6
4 23 11 22 8
5 82 20 78 7
Total 324 132 372 75
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proteins was further examined using the results from the mass
spectrometry characterization. As an initial analysis we deter-
mined the top 10 most abundant glycoproteins from each cell
line. The expression of these abundant proteins were esti-
mated and ranked by spectral counts and unique peptides as
shown in Table IIA and Table IIB. We then compared the
relative abundance of these top 10 glycoproteins, as de-
rived from the sialoglycoprotein-targeted enrichment/isola-
tion, between the ManNaz and ManNAc labeled cells.
Based upon this comparison, the top most abundant gly-
coproteins were present in far higher incidence from the
ManNAz-treated group. We observed a similar enrichment
by the ManNAz group when we employed emPIA score to
rank the glycoproteins (see supplemental Table 3). These
results clearly demonstrate a substantial increase in the
selective capture of the most abundant known cellular gly-
coproteins via this methodology.
As a final assessment of the extent of enrichment of glyco-
proteins on the cell surface and in the extracellular compart-
ment, we compared our targeted method to a nonselective
global proteomic analysis of whole-cell lysates of the same
FIG. 4. Improved capture of known glycoproteins. Identified pro-
teins were cross-referenced to the UniProt Knowledgebase for known
glycoproteins. The percent of total proteins that were matched to
known glycoproteins is shown, in comparison to that typically deter-
mined by global proteomic approaches.
FIG. 5. Subcellular location of identified proteins. The cellular
location was determined by cross-referencing the annotations from
UniProtKB. Each protein was designated with only one subcellular
location. The protein classes are shown as percent of total protein on
the x axis. This analysis was conducted for both the surface glyco-
protein and global methodologies.
TABLE II
Most abundant glycoproteins identified in the N2 and ML2 cell lines. *p  0.0015 (N2);  0.0001 (ML2)
A. N2 Cells
Acc # Protein N2-ManNAz N2-ManNAc
Spect-counts Uniq-pep Spect-counts Uniq-pep
1 O75694 Nuclear pore complex protein Nup155 21 17 4 3
2 P05556 Integrin -1 64 14 0 0
3 P14625 Endoplasmin 17 10 6 3
4 P26006 Integrin -3 7 5 0 0
5 P17301 Integrin -2 7 5 0 0
6 P15144 Amin opeptidase N 8 4 0 0
7 P02786 Transferrin receptor protein 1 6 4 3 2
8 P16144 Integrin -4 5 4 0 0
9 P16070 CD44 antigen 6 3 0 0
10 O00592 Podocalyxin-like protein 1 6 3 0 0
B. ML2 Cells
Acc # prot_desc ML2-ManNAz ML2-ManNAc
Spect-counts Uniq-pep Spect-counts Uniq-pep
1 P05556 Integrin -1 75 14 0 0
2 P15144 Amino peptidase N 21 14 0 0
3 O75694 Nuclear pore complex protein Nup155 20 11 2 2
4 P17301 Integrin -2 17 10 0 0
5 P16144 Integrin -4 10 8 0 0
6 P14625 Endoplasmin 16 7 2 1
7 P02786 Transferrin receptor protein 1 10 7 1 1
8 Q02413 Desmoglein-2 7 5 0 0
9 P35613 Basigin 11 4 0 0
10 P26006 Integrin -3 9 4 0 0
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TABLE III
Cell-surface N-linked glycoproteins overexpressed in N2 cells






4 4 P28290 SSFA2 Sperm-specific antigen 2 139,554 170,000 Actin binding
1 1 Q92667 AKAP1 Akinase anchor protein 1,
mitochondrial
98,250 120,000 Protein binding
1 1 Q00341 HDLBP Vigilin 141,995 140,000 Sterolmetabolism
1 1 Q8NFJ5 GPRC5A Retinoic acid-induced protein 3 40,624 300,000 Signal transduction
4 3 Q9Y678 COPG Coatomer subunit  98,967 90,000 ER-Golgi vesicle transport
1 1 P50416 CPT1A Carnitine O-
palmitoyltransferase 1, liver
isoform
88,995 300,000 Lipid metabolism
2 2 P35222 CTNNB1 Catenin -1 86,069 90,000 Cell adhesion; signal
transduction
1 1 O60716 CTNND1 Catenin -1 108,674 100,000 Cell adhesion; signal
transduction
1 1 P08174 CD55 Complement decay-
accelerating factor
42,400 75,000 Complement activation
3 3 Q7L2E3 DHX30 Putative ATP-dependent RNA
helicase DHX30
134,938 130,000 ATP binding
1 1 O60610 DIAPH1 Protein diaphanoushomolog 1 141,942 140,000 Receptor binding
1 1 Q8TDM6DLG5 Disks large homolog 5 215,446 240,000 Cell adhesion; signal
transduction
3 2 P50570 DNM2 Dynamin-2 98,345 95,000 Vesicular trafficking
1 1 Q9BW60ELOVL1 Elongation of very long chain
fatty acids protein 1
32,755 300,000 Fatty acid biosynthesis
1 1 O95864 FADS2 Fatty acid desaturase 2 52,340 300,000 Lipid metabolism
1 1 Q05397 PTK2 Focal adhesion kinase 1 119,956 120,000 Integrin-mediated signaling
pathways
11 7 Q92616 GCN1L1 Translational activator GCN1 294,953 300,000 Translation activator
2 1 Q8TCT9 HM13 Minor histocompatibility
antigen H13
41,747 300,000 Proteolysis; protein binding
1 1 Q86YT6 MIB1 E3 ubiquitin-protein ligase
MIB1
112,461 110,000 Notch signal pathway,
ubiquitination regulation
1 1 Q9UM54MYO6 Myosin-VI 150,965 150,000 Protein transport;
endocytosis
12 4 Q5SRE5 NUP188 Nucleoporin NUP188 homolog 198,369 220,000 Component of the nuclear
pore complex (NPC)
1 1 O75781 PALM Paralemmin 42,221 60,000 Cell shape
1 1 O00408 PDE2A cGMP-dependent 3,5-cyclic
phosphodiesterase
107,360 50,000 Signal transduction
1 1 P13796 LCP1 Plastin-2 70,815 70,000 T-cell activation; intracellular
protein transport
2 1 Q8TEM1 NUP210 Nuclear pore membrane
glycoprotein 210
205,895 300,000 Protein transport
6 3 O75400 PRPF40A Pre-mRNA-processing factor
40 homolog A
109,022 120,000 mRNA processing
1 1 Q63HN8 RNF213 RING finger protein 213 378,474 300,000 Nucleoside-triphosphatase
activity
4 3 O15027 SEC16A Protein transport protein Sec
16A
234,855 250,000 ER-Golgi transport
1 1 Q15437 SEC23B Protein transport protein
Sec23B
87,393 80,000 ER-Golgi transport
2 2 P53992 SEC24C Protein transport protein
Sec24C
119,779 120,000 ER-Golgi transport




81,104 300,000 N-linked glycosylation
1 1 Q92797 SYMPK Symplekin 141,915 140,000 Cell adhesion; mRNA
processing
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cell model. Whole-cell lysates were prepared from N2 and
ML2 cells, directly digested by trypsin and subjected to LC-
MS/MS as described in materials and methods. Three nano-
LC-MS/MS runs of tryptic digests showed that a significant
number of total proteins (310 for N2 and 280 for ML2) could
be detected using this simple nonfractionation approach (see
supplemental Table 4). When analyzed for protein content, we
found that 3.8% of the N2 proteome and 2.9% of the ML2
proteome identified from this global approach were annotated
as glycoproteins using the UniProt database. In comparison,
our targeted approach yielded 9.3% and 13.5% respectively
(Fig. 4). Although the use of the UniProt database to deter-
mine if a protein is glycosylated is notoriously under-repre-
sentative, a fourfold enrichment was revealed. Most striking
was that 10 of 12 internal glycoproteins, found to be abundant
and identified in the targeted approach, were not identified in
the whole-cell proteome approach.
We next conducted a comparative analysis of the two ap-
proaches with specific emphasis on which cellular compart-
ment the proteins were derived. Fig. 5 displays the UniProt-
designated subcellular distribution of proteins identified in the
global proteomic approach and the surface sialoglycoprotein
targeted approach. We observed that about 13.2% of pro-
teins from the whole-cell analysis of N2 and ML2 were clas-
sified as being extracellular and membrane-bound. This result
is consistent with studies using whole-cell approaches to
examine breast cancer cell (33) and ovarian cancer cell pro-
teome (34). In contrast, our cell-surface glycoprotein ap-
proach resulted in a proteome for N2 and ML2 with 25.9%
and 29.8% of proteins being secreted or cell-surface pro-
teins, respectively. These cell-surface proteins include clus-
ter differentiation markers, cell surface receptors, mem-
brane transport, and cell adhesion proteins, such as CD44,
CD166, integrins, anexins, calnexin, etc. In contrast, a small
portion of proteins identified using our targeted approach
were classified as having endoplasmic reticulum/Golgi lo-
cation (2%). A large portion of proteins were classified as
intracellular (50%), either cytoplasm or nucleus, whereas
18 proteins for N2 and 13 proteins for ML2 remain unclas-
sified. Recently, Sardana et al. conducted a cellular “secre-
tome” analysis in which the conditioned medium of three
prostate cancer cell lines (including PC3) was examined.
They identified 2000 proteins of which 12% were classi-
fied as known extracellular proteins (35). Our surface glyco-
protein approach observed 32 proteins that were in com-
mon with this “secretome” study and that 85% of these
were classified as membrane proteins. These findings un-
derscore the value of our targeted strategy to capture and
isolate cell-surface glycoproteins.
Selective Identification of Differentially Expressed Cell-sur-
face Sialoglycoproteins—Currently less than 5% of proteins
are annotated as glycoproteins in the UniProt database (36).
This is a striking number when current estimates suggest that
more than 50% of eukaryotic proteins are glycosylated.
Therefore, we assembled the identified proteins that could
be attributed to membrane-bound and extracellular com-
partments by UniProt database or predicted to contain
transmembrane domains (SOSUI, TMHMM). These were
further analyzed for the prediction of sites for N-linked
glycosylation (NetNGlyc). Using these criteria, we compared
the surface sialoglycoprotein expression profiles of the met-
astatic variants. Ultimately, 36 and 44 cell-surface glyco-
proteins were uniquely identified in N2 and ML2 respec-
tively. A list of these proteins, their UniProt accession
number, and molecular function is presented in Table III
and IV (The annotated spectra for protein identifications
relying on a single peptide are available in supplemental
Tables 5 and 6). Known functions of these proteins include
cell-cell or cell-matrix adhesion, protein transporter, signal-
ing in response to cytokines and growth factors, induction
of coagulation, and proteolysis.
Functional Mapping of Differential Expressed Sialoglyco-
proteins—We next subjected the selected group of differentially
expressed cell-surface glycoproteins to analysis via IPA. Among
the 36 cell-surface glycoproteins unique to the nonmetastatic
N2 cells (Table III), many proteins, such as, complement decay-
accelerating factor (CD55), Catenin -1 (CTNNB1), focal
adhesion kinase 1 (PTK2), Myosin-VI (MYO6), A kinase an-
chor protein 1 (AKAP1), and symplekin (SYMPK), can pos-
itively or negatively regulate apoptosis pathway (Fig. 6) and
cell adhesion (catenin -1; CTNND1/disks large homolog
5;DLG5/symplekin; SYMPK). Other proteins overexpressed
reflect basic cell functions involving vesicular transport, lipid
metabolism and mRNA processing and splicing.
Conversely, the 44 cell-surface glycoproteins unique to the
metastatic ML2 cells (Table IV), a large number of proteins are
TABLE III—continued






4 3 Q9NXF1 TEX10 Testis-expressed sequence 10
protein
106,349 90,000 Unknown
1 1 O94901 UNC84A Protein unc-84 homolog A 90,806 300,000 Protein binding, cytoskeletal
anchoring
1 1 Q9H1C4 UNC93B1 Protein unc-93 homolog B1 66,930 300,000 Immunity; intracellular
protein transport
1 1 Q969M3 YIPF5 Protein YIPF5 28,370 40,000 ER-Golgi transport
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TABLE IV
Cell-surface N-linked glycoproteins overexpressed in ML2 cells






1 1 P08195 SLC3A2 4F2 cell-surface
antigen heavy chain
(CD98)
58,023 80,000 Cell growth; amino-acid
transport; carbohydrate
metabolism
1 1 P49748 ACADVL Very long-chain
specific acyl-CoA
dehydrogenase
70,745 70,000 Fatty acid metabolism
3 2 O95573 ACSL3 Long-chain-fatty-acid-
CoAligase 3
81,338 85,000 Fatty acid metabolism
3 2 Q5T9A4 ATAD3B ATPase family AAA
domain-containing
protein 3B
73,098 70,000 ATP binding
11 4 P35613 BSG Basigin 42,573 50,000–
70,000
Cell surface receptor
5 3 P27797 CALR Calreticulin 48,283 60,000 Molecular calcium binding
chaperone
1 1 Q01518 CAP1 Adenylyl cyclase-
associated protein 1
52,222 60,000 Cell polarity maintenance;
signal trasduction
1 1 Q96A33 CCDC47 Coiled-coil domain-
containing protein
47
56,123 65,000 Protein binding
4 2 Q9H5V8 CDCP1 CUB domain-
containing protein 1
94,241 130,000 Cell adhesion; tumor
progression and
metastasis
2 2 P12109 COL6A1 Collagen -1 (VI) chain 109,602 130,000 Cell adhesion
2 1 A8TX70 COL29A1 Collagen -5(VI) chain 291,796 120,000 Cell adhesion
1 1 Q15046 KARS Lysyl-tRNA synthetase 68,461 70,000 Protein biosynthesis
1 1 Q9BW27 NUP85 Nuclear pore complex
protein Nup85
75,826 75,000 Protein transport; mRNA
transport
1 1 Q9NZ01 TECR Synaptic glycoprotein 36,410 300,000 Lipid/steroid biosynthesis
1 1 Q02413 DSG1 Desmoglein-1 114,670 70,000 Cell adhesion




1 1 A6NKF9 GPR89C Putative protein
GPR89C
36,760 300,000 Unknown
1 1 P43304 GPD2 Glycerol-3-phosphate
dehydrogenase
81,296 80,000 Calcium ion binding
2 1 A1L0T0 ILVBL Acetolactate synthase-
like protein
68,452 70,000 Transferase activity;
magnesium ion binding




96,672 60,000 Ion transport
1 1 Q8TF66 LRRC15 Leucine-rich repeat-
containing protein
15
65,268 75,000 Protein binding
1 1 P29966 MARCKS Myristoylated alanine-
rich C-kinase
substrate




2 1 Q7Z434 MAVS Mitochondrial antiviral-
signaling protein
57,063 75,000 Innate immune defense
against viruses
1 1 Q8NHP6 MOSPD2 Motile sperm domain-
containing protein 2
60,051 60,000 Unknown
1 1 Q6PIF6 MYO7B Myosin-VIIb 243,612 250,000 Actin binding motor
activity
2 1 O15118 NPC1 Niemann-Pick C1
protein
144,868 250,000 Intracellular trafficking of
cholesterol
7 4 Q9UKX7 NUP50 Nucleoporin 50 kDa 50,512 60,000 Protein transport; mRNA
transport
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involved in cell movement, migration, and cell invasion. There
are 11 proteins involved in cell movement (Fig. 7). Notably, six
proteins, Basigin (BSG), Periostin (POSTN), Glucose-6-phos-
phate isomerase (GPI), Calreticulin (CALR), Leucine-rich re-
peat-containing protein 15 (LRRC15), and Myristoylated ala-
nine-rich protein kinase C substrate (MARCKS) are all
involved in the invasion of tumor cell lines. An additional five
proteins, Junction plakoglobin (JUP), Tyrosine-protein phos-
phatase nonreceptor type 1 (PTPN1), Niemann-Pick C1 pro-
tein (NPC1), Sodium-coupled neutral amino acid transporter 2
(SLC38A2), and Adenylyl cyclase-associated protein 1
(CAP1), are involved in cellular migration and/or movement.
Six of the aforementioned proteins (SLC38A2, JUP, PTPN1,
POSTN, CALR, and BSG) and Pinin (PNN), CUB domain-
containing protein 1 (CDCP1), DNA-directed RNA polymerase
I subunit RPA49 (POLR1E), and Collagen -1(VI) chain
(COL6A1), are involved in growth/colony formation. Cumula-
tively, the types of glycoproteins that were differentially ex-
pressed in the N2 and ML2 cells functionally reflect their
respective nonmetastatic and metastatic phenotypes.
Verification of the Expression of Integrin 1 and
CDCP1—We next employed orthoganol approaches to exam-
ine two candidate proteins as a verification of the ability of the
described methodology to target sialoglycoproteins that are
differentially expressed across our cell model. We targeted
Integrin 1 and CDCP1 for further analysis and would propose
that such verification be a routine component of our work-
flow. Integrin 1 (CD29) was identified in both N2 and ML2
cells, where as CDCP1 was uniquely identified in the meta-
static ML2 cell line. We first examined the cell surface glyco-
TABLE IV—continued
Cell-surface N-linked glycoproteins overexpressed in ML2 cells






1 1 Q6V1P9 DCHS2 Protocadherin-23 323,744 55,000 Cell adhesion
1 1 Q9H307 PNN Pinin 81,679 130,000 Cell adhesion; mRNA
processing
8 6 P14923 JUP Junction plakoglobin 82,434 85,000 Junctional plaque
formation
1 1 Q15063 POSTN Periostin 93,883 70,000 Cell adhesion
4 3 P18031 PTPN1 Tyrosine-protein
phosphatase non-
receptor type 1
50,505 55,000 Regulation of insulin signal
pathways
8 7 P46060 RANGAP1 RanGTPase-activating
protein 1
63,958 80,000 Signal transduction
1 1 Q9GZS1 POLR1E DNA-directed RNA poly-
merase I subunit
RPA49
54,441 55,000 rRNA transcription





68,641 70,000 N-linked glycosylation
1 1 Q9Y265 RUVBL1 RuvB-like 1 50,538 60,000 Cell cycle; cell division,
growth regulation
1 1 Q96QD8 SLC38A2 Sodium-coupled neutral
amino acid transporter
2
56,332 300,000 Amino-acid transport







3 2 P35498 SCN1A Sodium channel protein
type 1 subunit 
230,876 300,000 Ion transport
2 1 O15269 SPTLC1 Serine
palmitoyltransferase 1
53,281 50,000 Lipid metabolism
1 1 O00186 STXBP3 Syntaxin-binding protein
3
68,633 70,000 Vesicle docking in
exocytosis
7 4 O94826 TOMM70A Mitochondrial import
receptor subunit
TOM70
68,096 75,000 Receptor for protein
import into mitochondria
3 1 Q15849 SLC14A2 Urea transporter, kidney 102,213 70,000 Urea transporter
1 1 P38606 ATP6V1A V-type proton ATPase
catalytic subunit A
68,660 70,000 ATP synthesis coupled
proton transport
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protein enriched eluents derived from the streptavidin-based
purification shown in Fig. 3B. An equal volume of surface
enriched fractions from N2 and ML2 cells and their respective
controls was resolved by SDS-PAGE and probed with anti-
bodies to the indicated proteins. When analyzed for Integrin
1, a band with an apparent molecular weight of 130 kDa was
found in N2 and ML2 ManNAz-treated cells at similar abun-
dance (Fig. 8A, top panel), consistent with the observed LC-
MS/MS results. Immunoblotting for CDCP1 revealed the 135
kDa full-length form as well as a 70 kDa truncated species
(truncated species not shown). The CDCP1 levels were four-
fold greater on the surface of ML2 compared with N2 cells
(Fig. 8A, middle panel). The ManNAc-labeled control cells
exposed to the same enrichment procedure had undetectable
levels of the selected proteins, underscoring the efficiency of
our surface glycoproteomic strategy. The consistent amounts
of SAv across all samples served as a control for normaliza-
tion of the data. This result provides verification of the relative
expression of these proteins.
We then determined the expression of the target proteins
directly from whole-cell lysates derived from N2 and ML2.
Western blot analysis of these extracts confirmed a uniform
expression of Integrin 1 between N2 and ML2 (Fig. 8B, top
panel). However, the analysis of CDCP1 (135 kDa) showed that
expression in ML2 total cell lysate was higher (1.6-fold) than N2
lysate (Fig. 8B, middel panel). The expression results were nor-
malized to the endogenous levels of GAPDH. It is interesting to
note that although the expression of total CDCP1 is higher in
ML2 than N2 it seems that the surface expression of CDCP1 is
the most striking difference in this cell model.
We next addressed the glycosylation status of the selected
proteins to determine the effectiveness of our approach to
FIG. 6. Functional pathway analysis of glycoproteins overexpressed in PC3-N2. Ingenuity Pathway Analysis (IPA) was employed to
functionally map the cell-surface glycoproteins overexpressed in PC3-N2 cells. The network shows the biological functions (Fx) that have been
associated with these glycoproteins in the context of disease. “Apoptosis of tumor cell lines” is the top listed function, as determined by the
number of overexpressed glycoproteins (highlighted in blue) associated with this activity. Individual proteins with known biochemical activities
are highlighted with class-specific shapes (indicated in the legend).
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target sialoglycoproteins. Whole-cell extracts were treated
with Protein N-glycosidase F (PNGase F), which efficiently
cleaves N-linked glycans, and neuraminidase, which hydro-
lyzes only the terminal sialic acid residues. The digested and
undigested extracts were separated by SDS-PAGE, and sub-
jected to Western blot analysis. The analysis of integrin 1
showed that PNGase F treatment resulted in the disappear-
ance of the 130 kDa band and coincident generation of a
lower molecular weight band of 90 kDa (Fig. 8C, upper
panel). Likewise, deglycosylation with PNGase F led to a mass
shift of about 40 kDa for CDCP1 (Fig. 8C, middle panel). These
results clearly demonstrate that integrin 1 and CDCP1 are
heavily N-glycosylated. When examined for specific sialyla-
tion we observed that neuraminidase (Neura) treatment re-
sulted in a reduction in the apparent mass for integrin 1 and
CDCP1 (Fig. 8D), indicating a higher sialic acid content in
N-glycans of both protein species. This result is consistent
with our approach being able to successfully target sialogly-
coproteins and identify those that are differentially expressed
in our model.
DISCUSSION
Metastatic spread of cancer involves tumor cell extravasa-
tion and subsequent invasion of surrounding tissue, all pro-
cesses that are tightly regulated by cell surface mechanisms
(37, 38). The identification of surface-accessible glycopro-
teins, which are altered in the metastatic process, will help to
unfold the underlying biological events that support cancer
metastasis. Developing experimental approaches to selec-
tively interrogate surface glycoproteins should facilitate the
discovery of new biomarkers for cancer diagnosis, prognosis,
FIG. 7. Functional pathway analysis of glycoproteins overexpressed in PC3-ML2. Ingenuity Pathway Analysis (IPA) was employed to
functionally map the cell-surface glycoproteins overexpressed in PC3-ML2 cells. The network shows the biological functions (Fx) that have
been associated with these glycoproteins in the context of disease. “Cell movement” and “invasion” are the top listed functions, as determined
by the number of glycoproteins (highlighted in blue) associated with these activities. Individual proteins with known biochemical activities are
highlighted with class-specific shapes (indicated in the legend).
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and help define new therapeutic targets. In this study, a novel
surface glycoprotein targeted strategy, based on metabolic
labeling and click chemistry, was developed for purification
and characterization of sialoglycoproteins. Metabolic labeling
of glycans with sugar analogues and subsequent probe cap-
ture via click chemistry has been applied to cellular micros-
copy (39, 40). However, to our knowledge, our data is the first
to demonstrate its application in targeted proteomics.
Click chemistry refers to a bioorthogonal ligation event
between azide and alkyne (31). Because of its small size,
metabolic stability, and lack of reactivity with natural biofunc-
tional structures, azides can be metabolically introduced into
cellular substrates with minimal physiological perturbation.
The Cu-catalyzed azide-alkyne cycloaddition click reaction
offers high-sensitivity and high-specificity for azide detection.
Our flow cytometry results and confocal images confirmed the
high selectivity and specificity of click chemistry for labeling
cell-surface sialoglycoconjugates. We further demonstrated
that click conjugation of biotin allowed for selective and effi-
cient isolation of sialoglycoproteins. The ready availability of
metabolic probes targeting alternative glycans makes this an
attractive strategy for targeting other classes of glycoproteins.
Currently there are commercially available Click-friendly prod-
ucts for labeling of O-linked, O-linked N-acetylglucosamine
modified, sialic acid modified and fucosylated glycoproteins.
GeLC-MS/MS analysis of the targeted proteins revealed a
proteome that was enriched to 29% for cell surface or
excreted proteins. This compares favorably with other pro-
teomic approaches using a nonselective surface biotinylation
and MudPIT analysis (34, 41), in which cell-surface protein
enrichment of 30% was reported for human ovarian cancer
cell lines. More recently, generic glycan capture followed by
the specific release of N-linked glycosylated peptides via
peptide-N-glycosidase F and LC-MS/MS has been reported
to successfully identify N-linked glycopeptides (26). Because
the authors assumed that all proteins identified by the ap-
proach were glycoproteins there was no report of target effi-
ciency. Aebersold and coworkers adapted this system to
target surface membrane glycoproteins (42) and McDonald et
al. demonstrated improved glycoprotein capture using lectin
affinity based enrichment (43). Although both glycan capture
strategies were successful, the technology is still challenging
because of a potential for false positive identification that
arises from the dependence on single peptide analysis, 1 Da
glycan shift and competition with natural Asn to Asp conver-
sion. To eliminate the false positive identification of the N-
linked peptides, MS data acquisition from more intense iso-
topic peaks and manual inspection of mass spectra are
required. Because N-linked glycosylation predominates in
secreted and cell-surface proteins, we would suggest that
combining a selective click chemistry approach as we have
described with this gel-free system for the analysis of the
cell-surface glycoproteome would be a successful alternative
strategy.
The significant number of proteins annotated as nuclear or
cytoplasmic that were present among our cell-surface sia-
loglycoproteome is noteworthy. To some extent, occurrence
of these predominantly intracellular proteins may be because
of their high abundance. Despite our efforts to optimize the
labeling protocol and increase wash stringency, some pro-
teins classified as intracellular were still precipitated by the
SAv resin. High-salt (1.5 M NaCl) and high-pH (0.1 M Na2CO3)
FIG. 8. Characterization of Integrin
1 and CDCP1 Expression. A, Western
blot analysis of cell-surface glycoprotein
enriched fractions. N2 and ML2 cells
were metabolically labeled with ManNAz
or ManNAc, conjugated with biotin-
alkyne and isolated via streptavidin. The
purified eluates from each group were
separated by SDS-PAGE, and immuno-
blotted for selected proteins as de-
scribed. Streptavidin (SAv) was analyzed
to normalize for loading. B, Western blot
analysis of expression of the indicated
proteins in total lysates of N2 and ML2
cells. Anti-GAPDH was included as a
loading control. (C, D) Characterization
of the glycosylation status of integrin 1
and CDCP1. Total cell lysates (20 g) of
N2 and ML2 cells were subjected to di-
gestions with PNGase F (C) or neuramin-
idase (D) as described and then sub-
jected to SDS-PAGE. The separated
proteins were analyzed by Western blot
analysis as described. Analysis of en-
dogenous GAPDH or  actin was in-
cluded as a loading control.
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buffers have been reported to reduce such contamination and
may reduce this background (44, 45). Another possible reason
for the contamination is limited cell death during the click
reaction. The reaction requires copper as a catalyst, which is
toxic to the cell (46). Fortunately, a new generation click
chemistry is available and has been shown to maximally pre-
serve cell viability through bypassing the requirement of cop-
per (47). Bertozzi’s group applied copper-free click chemistry
for dynamic in vivo imaging, claiming comparable kinetics to
the copper-catalyzed reaction and speed with no apparent
toxicity (47). We have similarly observed identical labeling
performance and selectivity with much less cytotoxicity when
cells were labeled with these copper-free reagents (data not
shown). Improving cell viability could improve proteome se-
lectivity and would also allow for kinetic experiments post-
reaction via click. Finally, one must consider existing evidence
for the occurrence of cytoplasmic proteins bound to the ex-
tracellular membrane or exposed on the cell surface, partic-
ularly in aggressive cancer cells (48–50). Thus, a portion of
our “cytoplasmic” proteins that we detected may be associ-
ated with glycosylated surface binding partners. For this rea-
son it is critical to employ robust orthoganol verification of the
identified proteins similar to the strategy we described for
verification of integrin 1 and CDCP1 in our system.
In addition to the enriched recovery of surface glycopro-
teins the identification of proteins differentially expressed be-
tween the nonmetastatic (N2) and metastatic (ML2) prostate
cancer cell lines was supportive of our model system. Our
findings revealed substantial changes in the abundance of
proteins that have previously been associated with metastatic
spread of cancer and the discovery of some new cell-surface
sialoglycoproteins with potential roles in metastasis. The en-
richment for surface glycoproteins demonstrated by this
method provides proof of concept of the utility of this ap-
proach in the discovery of sialic acid-containing glycoproteins
of disease significance. Although many cellular proteins are
glycosylated, they are rarely identified by global proteomics
approaches. We demonstrated that enrichment for surface
sialoglycoproteins facilitates identification of biologically rele-
vant surface proteins including a substantial enrichment of
cell-surface glycoproteins of low abundance. These included
adhesion proteins implicated in cancer development such as
protocadherin-23 and CUB-domain containing protein 1, pro-
tein binding and signal transduction molecules such as leu-
cine-rich repeat-containing protein 15 and focal adhesion
kinase 1. The success at identification of low abundance
surface glycoproteins is likely a result of the selective simpli-
fication of the complexity of a cellular proteome.
In summary, we describe a glycoproteomic strategy for the
analysis of specific subclasses of cell-surface glycoproteins.
The approach combines selective metabolic labeling of cell-
surface glycans, affinity purification of sialylated proteins,
SDS-PAGE separation, and subsequent LC-MS/MS for pro-
tein identification. A total of 80 proteins differentially ex-
pressed among cell lines were identified, including many in-
tegral plasma membrane glycoproteins that were not reported
by previous proteomic analyses. Given the importance of the
cell-surface glycoproteins for drug design, biomarker discov-
ery, and the regulation of cellular behaviors, the described
protocol is a useful addition to currently available tools to
expedite the discovery of new cancer biomarker and thera-
peutic targets in diseases and delineation of signal transduc-
tion pathways.
Acknowledgments—We thank Dr. Mark E. Stearns at Drexel Uni-
versity for kindly providing us PC3-N2 and PC3-ML2 cells, and Mi-
chael D. Ward at our group for his excellent technical assistance with
LC-MS/MS analysis.
* This work was funded in part by National Institutes of Health
National Cancer Institute Grants R01 CA135087 (R. R. D.) and U01
CA085067 (O. J. S.).
□S This article contains supplemental Figs. S1 to S3 and
Tables S1 to S4.
¶ To whom correspondence should be addressed: Department of
Microbiology and Molecular Cell Biology, Eastern Virginia Medical
School, Norfolk, Virginia 23507. Tel.: 757-446-5904; Fax: 757-446-
5766; Email: semmesoj@evms.edu.
REFERENCES
1. Apweiler, R., Hermjakob, H., and Sharon, N. (1999) On the frequency of
protein glycosylation, as deduced from analysis of the SWISS-PROT
database. Biochim. Biophys. Acta 1473, 4–8
2. Varki, A. (1993) Biological roles of oligosaccharides: all of the theories are
correct. Glycobiology 3, 97–130
3. Taniguchi, N., Miyoshi, E., Gu, J., Jianguo, G., Honke, K., and Matsumoto,
A. (2006) Decoding sugar functions by identifying target glycoproteins.
Curr. Opin. Struct. Biol. 16, 561–566
4. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., and Dwek, R. A. (2001)
Glycosylation and the immune system. Science 291, 2370–2376
5. Roth, J. (2002) Protein N-glycosylation along the secretory pathway: rela-
tionship to organelle topography and function, protein quality control,
and cell interactions. Chem. Rev. 102, 285–303
6. Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi,
C. R., and Hart, G. W. (2009) Essentials of glycobiology. 2nd Ed., Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
7. Drake, P. M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N. L.,
Regnier, F. E., Gibson, B. W., and Fisher, S. J. (2010) Sweetening the pot:
adding glycosylation to the biomarker discovery equation. Clin. Chem.
56, 223–236
8. Dwek, M. V., and Brooks, S. A. (2004) Harnessing changes in cellular
glycosylation in new cancer treatment strategies. Curr. Cancer Drug
Targets 4, 425–442
9. Lau, K. S., and Dennis, J. W. (2008) N-Glycans in cancer progression.
Glycobiology 18, 750–760
10. Ono, M., and Hakomori, S. (2004) Glycosylation defining cancer cell motility
and invasiveness. Glycoconj. J. 20, 71–78
11. Miyagi, T., Wada, T., Yamaguchi, K., and Hata, K. (2004) Sialidase and
malignancy: a minireview. Glycoconj. J. 20, 189–198
12. Varki, N. M., and Varki, A. (2007) Diversity in cell surface sialic acid pre-
sentations: implications for biology and disease. Lab. Invest. 87,
851–857
13. Fogel, M., Altevogt, P., and Schirrmacher, V. (1983) Metastatic potential
severely altered by changes in tumor cell adhesiveness and cell-surface
sialylation. J. Exp. Med. 157, 371–376
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